Skip to main content

Table 5 Subgroup analyses of the association between Calcium-channel blockers (CCBs), Angiotensin-receptor blockers (ARBs) or Angiotensin-converting enzyme inhibitors (ACEIs) use and risk of ovarian cancer mortality

From: Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study

  1. aCox model, adjusted for age, place of residence, CCI, stage, histology, surgery, chemotherapy, radiotherapy, use of anticoagulants, statins, antidiabetics, antihypertensive medications 1-year pre-diagnosis. Mutually adjusted for the AH medications use 1-year after diagnosis. bIncluding mucinous, endometrioid and other
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us